... with longer follow up, had similar rates of infections and second primary malignancies, with no observed unexpected gene therapy-related toxicities.
https://www.google.com/url?rct=j&sa=t&url=https://www.healio.com/news/hematology-oncology/20210810/bcmadirected-cart-still-shows-deep-durable-response-in-heavily-pretreated-myeloma&ct=ga&cd=CAIyGmEyNDJjNTAxZWU3OTQyNzI6Y29tOmVuOlVT&usg=AFQjCNGDuUqTF14RswG17ROQGDCDvIo3tw
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.